SUNBEAM: following babies to understand early childhood allergies
Official title: SUNBEAM Birth Cohort Supplement
Funded at National Jewish Health · NIH-11358688 · Data updated 2026-11-12
This project follows infants and young children to find early-life signs and causes of allergies and asthma.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | National Jewish Health NIH-funded |
| Lab location | 1 site (Denver, United States) |
| Project start | September 6, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $200,000 |
| NIH project number | 3U01AI173502-02S1 |
| Project ID | NIH-11358688 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are newborns or infants (and their parents/caregivers) willing to attend follow-up visits and provide clinical information and biological samples through early childhood.
✕Less likely to help
Adults or children well beyond early childhood with established, long-standing allergic disease are unlikely to receive direct benefit from this birth-cohort effort.
What this research studies
You and your child would join a group of newborns and toddlers who are followed over the first years of life to track allergy symptoms and lung health. Researchers collect health histories, questionnaires about feeding and environment, and biological samples at clinic visits to look for immune changes and sensitizations. The team links those findings to symptoms like food allergy, allergic rhinitis, and asthma to spot patterns that appear before disease develops. Participation typically involves regular visits, sample collection, and sharing medical information over time.
Why it matters
Potential benefit: If successful, the work could help identify early markers of allergy risk so doctors can intervene sooner or tailor prevention for children.
How similar studies have gone: Other birth-cohort studies have successfully identified early-life risk factors for allergies and asthma, so this approach builds on proven methods.
Where this research is happening
-
National Jewish Health
Denver, United States Active
Researchers
- Principal investigator: Seibold, Max a — National Jewish Health
- Study coordinator: Seibold, Max a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.